Groowe Groowe / Newsroom / NVS
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

NVS News

Novartis AG

Oncology Clinical Trials Market Forecast 2026-2035 - AI Revolutionizes Oncology Clinical Trials: Boosts Recruitment, Optimizes Protocols

globenewswire.com
AZN MRK NVS

Aircraft Ground Support Equipment Market to Hit USD 19.7 Billion by 2035 as Smart Airport Investments and Electrification Accelerate

prnewswire.com
TT HON GE BA GD LMT RTX AVAV ALGN AMZN GOOG MSFT IBM SAP ORCL INTC NVDA AMD QCOM MU AMAT LRCX KLAC ADI TXN MCHP NXPI ON INFY DXC CTAS PAYX ADP ACN VRSN CDNS SNPS MRVL ADSK PTC NOW CRM PANW FTNT ZBRA SMCI DELL HPQ LEN DHI NVR TOL PHM KBH BBY HD LOW TJX MDT AMGN GILD BMY PFE JNJ MRK ABBV LLY AZN NVS XOM CVX SHEL TTE COP MPC VLO PBF EOG APA OXY KMI ET BHP RIO VALE NEM FCX AA CLF STLD CF MOS NTR DD DOW LIN APD EMR MMM CAT DE AGCO CNH

EPRI Launches Flex MOSAIC to Reduce ‘Time to Power’ for Data Centers

globenewswire.com
GOOGL NVDA EXC DTE LNT SO PCG EIX PNW ETR PPL SRE CMS NI AEP XEL LUV HON SI LIN PEG ECL FE WEC NRG ED ES MDU NE UTL CWEN BEP TER MAS AMAT MU INTC AMD CDNS SNPS VRTX GILD AMGN BIIB REGN AZN NVS PFE MRK JNJ ABBV BMY LLY TEVA BCE CVE CP RY TD BNS CM CNQ SU BHP RIO VAL FCX AA STLD CF MOS NTR ADM BG CARR EMR GOOG META S VZ T TMUS CCI AMT EQIX DLR IBM MSFT AMZN CSCO LRCX KLAC ADI TXN ON NXPI INFY CTSH ACN

Anaveon appoints Biotech Leader Thaminda Ramanayake as Chief Executive Officer

globenewswire.com
CVAC BNTX SNY AMGN NVS PFE

Novartis presents new data on early symptom relief and long-term control in complex skin diseases at AAD 2026

globenewswire.com
NVS

ReflexMD GLP-1 Claims Evaluated: Safety Risks Assessed for Reflex MD Semaglutide Telemedicine Provider

globenewswire.com
NVS LLY

Novartis to Acquire Synnovation Therapeutics’ Pan-Mutant Selective PI3Kα Inhibitor Program

businesswire.com
NVS

Novartis agrees to acquire a pan-mutant-selective PI3Kα inhibitor, strengthening its breast cancer pipeline

globenewswire.com
NVS

Radioligand Therapeutics Market to More Than Double to $4.8 Billion by 2030 as Targeted Cancer Treatments Gain Regulatory Momentum

globenewswire.com
NVS LLY

BOOST Pharma Appoints Leading Biopharma Leader Elaine Jones as Chair

globenewswire.com
PFE NVS